| Serial Number | 98338329 |
| Word Mark | ORIONISBIO |
| Filing Date | Tuesday, January 2, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, April 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 3, 2024 |
| Goods and Services | Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; Pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Goods and Services | Diagnostic, biological and chemical reagents for scientific and research use; Pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases; Cytokines, namely, reagents for scientific and research use |
| Goods and Services | Development of new technology for others in the field of biotechnology; Scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; Biotechnical research; Technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development of pharmaceuticals for others; Scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Orionis Biosciences Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | Orionis Biosciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 30, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 30, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 30, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 30, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, April 10, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 11, 2025 | SOU EXTENSION 1 FILED |
| Friday, April 11, 2025 | SOU EXTENSION 1 GRANTED |
| Friday, April 11, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |